year
111Category: | Pharmaceuticals and Biochemicals |
|
|
CAS NO: | 27367-90-4 | ||
EC NO: | 248-431-5 | ||
Molecular Formula: | C20H25FN4O | ||
Molecular Weight: | 356.4371 | ||
Specification: | |||
InChI: | InChI=1/C20H25FN4O/c1-16(23-20(26)17-3-2-9-22-15-17)8-10-24-11-13-25(14-12-24)19-6-4-18(21)5-7-19/h2-7,9,15-16H,8,10-14H2,1H3,(H,23,26) | ||
Synonyms: | Niaprazine [INN:DCF];1709 CERM;5-23-01-00362 (Beilstein Handbook Reference);BRN 0844157;N-(3-(4-(4-Fluorophenyl)-1-piperazinyl)-1-methylpropyl)-3-pyridinecarboxamide;N-(3-(4-(p-Fluorophenyl)-1-piperazinyl)-1-methylpropyl)nicotinamide;Niaprazina;Niaprazina [INN-Spanish];Niaprazinum;Niaprazinum [INN-Latin];Nopron;UNII-R2H3YN6E3L;3-Pyridinecarboxamide, N-(3-(4-(4-fluorophenyl)-1-piperazinyl)-1-methylpropyl)- (9CI);Nicotinamide, N-(3-(4-(p-fluorophenyl)-1-piperazinyl)-1-methylpropyl)-;N-{4-[4-(4-fluorophenyl)piperazin-1-yl]butan-2-yl}pyridine-3-carboxamide; | ||
Molecular Structure: |